東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Collective behavior in two-dimension...

Guo, Chinlin.

Linked to FindBook

Google Book

Amazon

博客來

Collective behavior in two-dimensional biological systems: Receptor clustering and beta-sheet aggregation.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Collective behavior in two-dimensional biological systems: Receptor clustering and beta-sheet aggregation./
Author:	Guo, Chinlin.
Description:	86 p.
Notes:	Chairperson: Herbert Levine.
Contained By:	Dissertation Abstracts International62-09B.
Subject:	Biophysics, General. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3025945
ISBN:	0493381686

Collective behavior in two-dimensional biological systems: Receptor clustering and beta-sheet aggregation.
Guo, Chinlin.

Collective behavior in two-dimensional biological systems: Receptor clustering and beta-sheet aggregation. - 86 p.

Chairperson: Herbert Levine.

Thesis (Ph.D.)--University of California, San Diego, 2001.

We studied two particular biomedical systems which exhibit collective molecular behavior. One is clustering of tumor necrosis factor receptor I (TNFR1), and another is β-sheet folding and aggregation. Receptor clustering has been shown to be a crucial step in many signaling events but its biological meaning has not been adequately addressed. Here, via a simple lattice model, we show how cells use this clustering machinery to enhance sensitivity as well as robustness. On the other hand, intracellular deposition of aggregated protein rich in β-sheet is a prominent cytopathological feature of most neurodegenerative diseases. How this aggregation occurs and how it responds to therapy is not completely understood. Here, we started from a reconstruction of the H-bond potential and carry out a full investigation of β-sheet thermodynamics as well as kinetics. We show that β-sheet aggregation is most likely due to molecular stacking and found that the minimal length of an aggregate mutant polymer corresponds well with the number observed in adult Huntington's disease. We have also shown that molecular agents such as dendrimers might fail at high-dose therapy; instead, a potential therapy strategy is to block β-turn formation. Our predictions can be used for future experimental tests and clinical trials.

ISBN: 0493381686Subjects--Topical Terms:

1019105
Biophysics, General.

Collective behavior in two-dimensional biological systems: Receptor clustering and beta-sheet aggregation.
LDR:02263nam 2200277 a 45 001 936517
005 20110510
008 110510s2001 eng d
020 $a 0493381686
035 $a (UnM)AAI3025945
035 $a AAI3025945
040 $a UnM $c UnM
100 1 $a Guo, Chinlin. $3 1260204
245 1 0 $a Collective behavior in two-dimensional biological systems: Receptor clustering and beta-sheet aggregation.
300 $a 86 p.
500 $a Chairperson: Herbert Levine.
500 $a Source: Dissertation Abstracts International, Volume: 62-09, Section: B, page: 3936.
502 $a Thesis (Ph.D.)--University of California, San Diego, 2001.
520 $a We studied two particular biomedical systems which exhibit collective molecular behavior. One is clustering of tumor necrosis factor receptor I (TNFR1), and another is β-sheet folding and aggregation. Receptor clustering has been shown to be a crucial step in many signaling events but its biological meaning has not been adequately addressed. Here, via a simple lattice model, we show how cells use this clustering machinery to enhance sensitivity as well as robustness. On the other hand, intracellular deposition of aggregated protein rich in β-sheet is a prominent cytopathological feature of most neurodegenerative diseases. How this aggregation occurs and how it responds to therapy is not completely understood. Here, we started from a reconstruction of the H-bond potential and carry out a full investigation of β-sheet thermodynamics as well as kinetics. We show that β-sheet aggregation is most likely due to molecular stacking and found that the minimal length of an aggregate mutant polymer corresponds well with the number observed in adult Huntington's disease. We have also shown that molecular agents such as dendrimers might fail at high-dose therapy; instead, a potential therapy strategy is to block β-turn formation. Our predictions can be used for future experimental tests and clinical trials.
590 $a School code: 0033.
650 4 $a Biophysics, General. $3 1019105
650 4 $a Physics, General. $3 1018488
690 $a 0605
690 $a 0786
710 2 0 $a University of California, San Diego. $3 1018093
773 0 $t Dissertation Abstracts International $g 62-09B.
790 $a 0033
790 1 0 $a Levine, Herbert, $e advisor
791 $a Ph.D.
792 $a 2001
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3025945